Dental Drugs Market by Product Type (Anti-inflammatory drugs, Antibiotics, Pain killers, Fluoride, Anesthetics, Others); by Application (Academics/Institutes, Hospitals, Research Laboratories); by Regional Outlook (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Industry Trends, Price Trends, Growth, Size, Supply, Demand, Comparative Analysis, Competitive Market Share and Forecast, 2018-2026

Report ID :AMI-6 | Category : Healthcare | Published Date : March, 2018 | Pages : 290 | Format :PDF

Industry Trends

There are various drugs that dentist may recommend, depending on patient’s condition. Some medications are recommended to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. These variety of drugs include antibiotics, anti-inflammatory, pain killers, anesthetics, fluoride, and others. The guidelines on how to consume dental drugs varies from patient to patient, depending on what the drug is being used for, patient's age, weight, and other concerns. In terms of revenue, global dental drugs market, was valued at US$ 4.25 Mn in 2017 and is expected to reach US$ 5.43 Mn by 2022.

Global Dental Drugs Market, By Application, 2017 & 2022 (US$ Bn)

Dental Drugs

Rising rate of dental caries and other periodontal infections, increased endodontic cases, growing public awareness about dental care, growth in the geriatric population, and advancement in dental disease diagnostic and treatment technologies are the main factors driving the dental drugs market. In addition, growing awareness and patient empowerment have led to demand for better healthcare facilities at affordable prices. Extensive economic reforms and growing government spending has also played a vital role in the growth of this industry. Increasing healthcare awareness among mass population along with rise in prevalence rate of oral cavity diseases, is expected to propel the overall demand for dental drug worldwide. However, high cost and restricted repayment available for the treatment, proliferation of low-cost products, and the lack of talented dental experts are some of the factors hampering the growth of the market.

With increasing disposable incomes, the willingness to undergo expensive cosmetic procedures has also increased. There is a rising trend in the demand for dental restoration solutions and also aesthetic treatments like whitening, polishing, and preventive measures. Cosmetic dentistry is witnessing rapid growth in both developing as well as developed nations due to changing lifestyles and an increased desire to retain natural teeth. Dental drugs, one of the most rapidly growing segments in the dental markets, accounts for around 20% of the overall market for cosmetic dentistry procedures. 

Dental Drugs Market, by Application

On the basis of application, the hospital segment is expected to demonstrate the fastest growth during the forecasting period. Moreover, the hospitals segment also holds the largest market share. Numerous hospitals and nursing homes are providing dental services and tend to invest in foreign medical/dental drugs for providing quality and efficient dental care to the patients. Lately, this number has been showing an increasing trend to meet the growing demand of dental care industry.

Dental Drugs Market, by Region

North America dominates the overall market due to various factors, which include increasing government funding to dental programs, and high disposable income with the people. High awareness among working specialists and adults about oral care is another factor boosting the market in the region. North America represented a largest market share for the global dental drugs market, followed by Europe.

Competitive Landscape

The report provides both, qualitative and quantitative research of the market, as well as provides worthy insights into the rational scenario and favored development methods adopted by the key contenders. The dental drugs market report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as M&A, affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their manufacturing base, competitors, product type, application and specification, pricing, and gross margin.

Some of the primary participants are Bayer AG, Pfizer Deutschland GmbH, Dentsply International, Merck KGaA, AstraZeneca, Euticals S.p.a., Patterson Dental Supply, Inc., Septodont, Sunstar Suisse S.A., and Valeant, amongst others.

Dental Drug Industry Background

Dental Drugs

Dental Drugs

1.    Introduction

1.1.   Market Scope

1.2.   Market Segmentation

1.3.   Methodology

1.4.   Assumptions

2.    Dental Drugs Market Snapshot

3.    Executive Summary: Dental Drugs Market

4.    Qualitative Analysis: Dental Drugs Market

4.1.   Introduction

4.1.1.   Product Definition

4.1.2.   Industry Development

4.2.   Market Dynamics

4.2.1.   Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.3.   Trends in Market

5.    Global Dental Drugs Market Analysis and Forecasts, 2018 – 2026

5.1.   Overview

5.1.1.   Global Market Revenue (US$ Mn) and Forecasts

5.2.   Global Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

5.2.1.   Anti-inflammatory Drugs

5.2.1.1.    Definition

5.2.1.2.    Market Penetration

5.2.1.3.    Market Revenue Expected to Increase by 2026

5.2.1.4.    Compound Annual Growth Rate (CAGR)

5.2.2.   Antibiotics

5.2.2.1.    Definition

5.2.2.2.    Market Penetration

5.2.2.3.    Market Revenue Expected to Increase by 2026

5.2.2.4.    Compound Annual Growth Rate (CAGR)

5.2.3.   Pain Killers

5.2.3.1.    Definition

5.2.3.2.    Market Penetration

5.2.3.3.    Market Revenue Expected to Increase by 2026

5.2.3.4.    Compound Annual Growth Rate (CAGR)

5.2.4.   Fluoride

5.2.4.1.    Definition

5.2.4.2.    Market Penetration

5.2.4.3.    Market Revenue Expected to Increase by 2026

5.2.4.4.    Compound Annual Growth Rate (CAGR)

5.2.5.   Anesthetics

5.2.5.1.    Definition

5.2.5.2.    Market Penetration

5.2.5.3.    Market Revenue Expected to Increase by 2026

5.2.5.4.    Compound Annual Growth Rate (CAGR)

5.2.6.   Others

5.2.6.1.    Definition

5.2.6.2.    Market Penetration

5.2.6.3.    Market Revenue Expected to Increase by 2026

5.2.6.4.    Compound Annual Growth Rate (CAGR)

5.3.   Key Segment for Channeling Investments

5.3.1.   By Product type

6.    Global Dental Drugs Market Analysis and Forecasts, 2018 – 2026

6.1.   Overview

6.2.   Global Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

6.2.1.   Hospitals

6.2.1.1.    Definition

6.2.1.2.    Market Penetration

6.2.1.3.    Market Revenue Expected to Increase by 2026

6.2.1.4.    Compound Annual Growth Rate (CAGR)

6.2.2.   Academics/Institutes

6.2.2.1.    Definition

6.2.2.2.    Market Penetration

6.2.2.3.    Market Revenue Expected to Increase by 2026

6.2.2.4.    Compound Annual Growth Rate (CAGR)

6.2.3.   Research Laboratories

6.2.3.1.    Definition

6.2.3.2.    Market Penetration

6.2.3.3.    Market Revenue Expected to Increase by 2026

6.2.3.4.    Compound Annual Growth Rate (CAGR)

6.3.   Key Segment for Channeling Investments

6.3.1.   By Application

7.    North America Dental Drugs Market Analysis and Forecasts, 2018 – 2026

7.1.   Overview

7.1.1.   North America Market Revenue (US$ Mn)

7.2.   North America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

7.2.1.   Anti-inflammatory Drugs

7.2.2.   Antibiotics

7.2.3.   Pain Killers

7.2.4.   Fluoride

7.2.5.   Anesthetics

7.2.6.   Others

7.3.   North America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

7.3.1.   Hospitals

7.3.2.   Academics/Institutes

7.3.3.   Research Laboratories

7.4.   North America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Country

7.4.1.   U.S.

7.4.1.1.    U.S. Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

7.4.1.1.1.    Anti-inflammatory Drugs

7.4.1.1.2.    Antibiotics

7.4.1.1.3.    Pain Killers

7.4.1.1.4.    Fluoride

7.4.1.1.5.    Anesthetics

7.4.1.1.6.    Others

7.4.1.2.    U.S. Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

7.4.1.2.1.    Hospitals

7.4.1.2.2.    Academics/Institutes

7.4.1.2.3.    Research Laboratories

7.4.2.   Rest of North America

7.4.2.1.    Rest of North America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

7.4.2.1.1.    Anti-inflammatory Drugs

7.4.2.1.2.    Antibiotics

7.4.2.1.3.    Pain Killers

7.4.2.1.4.    Fluoride

7.4.2.1.5.    Anesthetics

7.4.2.1.6.    Others

7.4.2.2.    Rest of North America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

7.4.2.2.1.    Hospitals

7.4.2.2.2.    Academics/Institutes

7.4.2.2.3.    Research Laboratories

7.5.   Key Segment for Channeling Investments

7.5.1.   By Country

7.5.2.   By Product type

7.5.3.   By Application

8.    Europe Dental Drugs Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.1.1.   Europe Market Revenue (US$ Mn)

8.2.   Europe Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

8.2.1.   Anti-inflammatory Drugs

8.2.2.   Antibiotics

8.2.3.   Pain Killers

8.2.4.   Fluoride

8.2.5.   Anesthetics

8.2.6.   Others

8.3.   Europe Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

8.3.1.   Hospitals

8.3.2.   Academics/Institutes

8.3.3.   Research Laboratories

8.4.   Europe Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Country

8.4.1.   France

8.4.1.1.    France Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

8.4.1.1.1.    Anti-inflammatory Drugs

8.4.1.1.2.    Antibiotics

8.4.1.1.3.    Pain Killers

8.4.1.1.4.    Fluoride

8.4.1.1.5.    Anesthetics

8.4.1.1.6.    Others

8.4.1.2.    France Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

8.4.1.2.1.    Hospitals

8.4.1.2.2.    Academics/Institutes

8.4.1.2.3.    Research Laboratories

8.4.2.   The UK

8.4.2.1.    The UK Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

8.4.2.1.1.    Anti-inflammatory Drugs

8.4.2.1.2.    Antibiotics

8.4.2.1.3.    Pain Killers

8.4.2.1.4.    Fluoride

8.4.2.1.5.    Anesthetics

8.4.2.1.6.    Others

8.4.2.2.    The UK Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

8.4.2.2.1.    Hospitals

8.4.2.2.2.    Academics/Institutes

8.4.2.2.3.    Research Laboratories

8.4.3.   Spain

8.4.3.1.    Spain Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

8.4.3.1.1.    Anti-inflammatory Drugs

8.4.3.1.2.    Antibiotics

8.4.3.1.3.    Pain Killers

8.4.3.1.4.    Fluoride

8.4.3.1.5.    Anesthetics

8.4.3.1.6.    Others

8.4.3.2.    Spain Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

8.4.3.2.1.    Hospitals

8.4.3.2.2.    Academics/Institutes

8.4.3.2.3.    Research Laboratories

8.4.4.   Germany

8.4.4.1.    Germany Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

8.4.4.1.1.    Anti-inflammatory Drugs

8.4.4.1.2.    Antibiotics

8.4.4.1.3.    Pain Killers

8.4.4.1.4.    Fluoride

8.4.4.1.5.    Anesthetics

8.4.4.1.6.    Others

8.4.4.2.    Germany Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

8.4.4.2.1.    Hospitals

8.4.4.2.2.    Academics/Institutes

8.4.4.2.3.    Research Laboratories

8.4.5.   Italy

8.4.5.1.    Italy Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

8.4.5.1.1.    Anti-inflammatory Drugs

8.4.5.1.2.    Antibiotics

8.4.5.1.3.    Pain Killers

8.4.5.1.4.    Fluoride

8.4.5.1.5.    Anesthetics

8.4.5.1.6.    Others

8.4.5.2.    Italy Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

8.4.5.2.1.    Hospitals

8.4.5.2.2.    Academics/Institutes

8.4.5.2.3.    Research Laboratories

8.4.6.   Rest of Europe

8.4.6.1. Rest of Europe Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

8.4.6.1.1.    Anti-inflammatory Drugs

8.4.6.1.2.    Antibiotics

8.4.6.1.3.    Pain Killers

8.4.6.1.4.    Fluoride

8.4.6.1.5.    Anesthetics

8.4.6.1.6.    Others

8.4.6.2.Rest of Europe Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

8.4.6.2.1. Hospitals

8.4.6.2.2.    Academics/Institutes

8.4.6.2.3.    Research Laboratories

8.5.   Key Segment for Channeling Investments

8.5.1.   By Country

8.5.2.   By Product type

8.5.3.   By Application

9.    Asia Pacific  Dental Drugs Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.1.1.   Asia Pacific Market Revenue (US$ Mn)

9.2.   Asia Pacific Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

9.2.1.   Anti-inflammatory Drugs

9.2.2.   Antibiotics

9.2.3.   Pain Killers

9.2.4.   Fluoride

9.2.5.   Anesthetics

9.2.6.   Others

9.3.   Asia Pacific Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

9.3.1.   Hospitals

9.3.2.   Academics/Institutes

9.3.3.   Research Laboratories

9.4.   Asia Pacific Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Country

9.4.1.   China

9.4.1.1.  China Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

9.4.1.1.1.    Anti-inflammatory Drugs

9.4.1.1.2.    Antibiotics

9.4.1.1.3.    Pain Killers

9.4.1.1.4.    Fluoride

9.4.1.1.5.    Anesthetics

9.4.1.1.6.    Others

9.4.1.2.    China Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

9.4.1.2.1.    Hospitals

9.4.1.2.2.    Academics/Institutes

9.4.1.2.3.    Research Laboratories

9.4.2.   Japan

9.4.2.1.    Japan Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

9.4.2.1.1.    Anti-inflammatory Drugs

9.4.2.1.2.    Antibiotics

9.4.2.1.3.    Pain Killers

9.4.2.1.4.    Fluoride

9.4.2.1.5.    Anesthetics

9.4.2.1.6.    Others

9.4.2.2.    Japan Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

9.4.2.2.1.    Hospitals

9.4.2.2.2.    Academics/Institutes

9.4.2.2.3.    Research Laboratories

9.4.3.   India

9.4.3.1.    India Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

9.4.3.1.1.    Anti-inflammatory Drugs

9.4.3.1.2.    Antibiotics

9.4.3.1.3.    Pain Killers

9.4.3.1.4.    Fluoride

9.4.3.1.5.    Anesthetics

9.4.3.1.6.    Others

9.4.3.2.    India Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

9.4.3.2.1.    Hospitals

9.4.3.2.2.    Academics/Institutes

9.4.3.2.3.    Research Laboratories

9.4.4.   Southeast Asia

9.4.4.1.  Southeast Asia Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

9.4.4.1.1.    Anti-inflammatory Drugs

9.4.4.1.2.    Antibiotics

9.4.4.1.3.    Pain Killers

9.4.4.1.4.    Fluoride

9.4.4.1.5.    Anesthetics

9.4.4.1.6.    Others

9.4.4.2. Southeast Asia Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

9.4.4.2.1.    Hospitals

9.4.4.2.2.    Academics/Institutes

9.4.4.2.3.    Research Laboratories

9.4.5.   Rest of Asia Pacific

9.4.5.1.  Rest of Asia Pacific Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

9.4.5.1.1.    Anti-inflammatory Drugs

9.4.5.1.2.    Antibiotics

9.4.5.1.3.    Pain Killers

9.4.5.1.4.    Fluoride

9.4.5.1.5.    Anesthetics

9.4.5.1.6.    Others

9.4.5.2.  Rest of Asia Pacific Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

9.4.5.2.1.    Hospitals

9.4.5.2.2.    Academics/Institutes

9.4.5.2.3.    Research Laboratories

9.5.   Key Segment for Channeling Investments

9.5.1.   By Country

9.5.2.   By Product type

9.5.3.   By Application

10. Middle East and Africa  Dental Drugs Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. Middle East and Africa Market Revenue (US$ Mn)

10.2. Middle East and Africa Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

10.2.1. Anti-inflammatory Drugs

10.2.2. Antibiotics

10.2.3. Pain Killers

10.2.4. Fluoride

10.2.5. Anesthetics

10.2.6. Others

10.3. Middle East and Africa Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

10.3.1. Hospitals

10.3.2. Academics/Institutes

10.3.3. Research Laboratories

10.4. Middle East and Africa Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Country

10.4.1. GCC Countries

10.4.1.1. GCC Countries Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

10.4.1.1.1.  Anti-inflammatory Drugs

10.4.1.1.2.  Antibiotics

10.4.1.1.3.  Pain Killers

10.4.1.1.4.  Fluoride

10.4.1.1.5.  Anesthetics

10.4.1.1.6.  Others

10.4.1.2. GCC Countries Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

10.4.1.2.1. Hospitals

10.4.1.2.2.  Academics/Institutes

10.4.1.2.3.  Research Laboratories

10.4.2. Southern Africa

10.4.2.1. Southern Africa Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

10.4.2.1.1.  Anti-inflammatory Drugs

10.4.2.1.2.  Antibiotics

10.4.2.1.3.  Pain Killers

10.4.2.1.4.  Fluoride

10.4.2.1.5.  Anesthetics

10.4.2.1.6.  Others

10.4.2.2. Southern Africa Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

10.4.2.2.1.  Hospitals

10.4.2.2.2.  Academics/Institutes

10.4.2.2.3.  Research Laboratories

10.4.3. Rest of MEA

10.4.3.1.  Rest of MEA Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

10.4.3.1.1.  Anti-inflammatory Drugs

10.4.3.1.2.  Antibiotics

10.4.3.1.3.  Pain Killers

10.4.3.1.4.  Fluoride

10.4.3.1.5.  Anesthetics

10.4.3.1.6.  Others

10.4.3.2. Rest of MEA Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

10.4.3.2.1.  Hospitals

10.4.3.2.2.  Academics/Institutes

10.4.3.2.3.  Research Laboratories

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Product type

10.5.3. By Application

11. Latin America Dental Drugs Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Latin America Market Revenue (US$ Mn)

11.2. Latin America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

11.2.1. Anti-inflammatory Drugs

11.2.2. Antibiotics

11.2.3. Pain Killers

11.2.4. Fluoride

11.2.5. Anesthetics

11.2.6. Others

11.3. Latin America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

11.3.1. Hospitals

11.3.2. Academics/Institutes

11.3.3. Research Laboratories

11.4. Latin America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Country

11.4.1. Brazil

11.4.1.1.  Brazil Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.1.1.1.  Anti-inflammatory Drugs

11.4.1.1.2.  Antibiotics

11.4.1.1.3.  Pain Killers

11.4.1.1.4.  Fluoride

11.4.1.1.5.  Anesthetics

11.4.1.1.6.  Others

11.4.1.2.  Brazil Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

11.4.1.2.1.  Hospitals

11.4.1.2.2.  Academics/Institutes

11.4.1.2.3.  Research Laboratories

11.4.2. Rest of Latin America

11.4.2.1.  Rest of Latin America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Product type

11.4.2.1.1.  Anti-inflammatory Drugs

11.4.2.1.2.  Antibiotics

11.4.2.1.3.  Pain Killers

11.4.2.1.4.  Fluoride

11.4.2.1.5.  Anesthetics

11.4.2.1.6.  Others

11.4.2.2.  Rest of Latin America Dental Drugs Market Revenue (US$ Mn) and Forecasts, By Application

11.4.2.2.1.  Hospitals

11.4.2.2.2.  Academics/Institutes

11.4.2.2.3.  Research Laboratories

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Product type

11.5.3. By Application

12. Competitive Benchmarking

12.1. Player Positioning Analysis

12.2. Global Presence and Growth Strategies

13. Player Profiles

13.1. AstraZeneca

13.1.1. Company Details

13.1.2. Company Overview

13.1.3. Product Offerings

13.1.4. Key Developments

13.1.5. Financial Analysis

13.1.6. SWOT Analysis

13.1.7. Business Strategies

13.2. Bayer AG

13.2.1. Company Details

13.2.2. Company Overview

13.2.3. Product Offerings

13.2.4. Key Developments

13.2.5. Financial Analysis

13.2.6. SWOT Analysis

13.2.7. Business Strategies

13.3. Dentsply Sirona

13.3.1. Company Details

13.3.2. Company Overview

13.3.3. Product Offerings

13.3.4. Key Developments

13.3.5. Financial Analysis

13.3.6. SWOT Analysis

13.3.7. Business Strategies

13.4. Euticals S.p.a

13.4.1. Company Details

13.4.2. Company Overview

13.4.3. Product Offerings

13.4.4. Key Developments

13.4.5. Financial Analysis

13.4.6. SWOT Analysis

13.4.7. Business Strategies

13.5. Merck KGaA

13.5.1. Company Details

13.5.2. Company Overview

13.5.3. Product Offerings

13.5.4. Key Developments

13.5.5. Financial Analysis

13.5.6. SWOT Analysis

13.5.7. Business Strategies

13.6. Patterson Dental Supply, Inc.

13.6.1. Company Details

13.6.2. Company Overview

13.6.3. Product Offerings

13.6.4. Key Developments

13.6.5. Financial Analysis

13.6.6. SWOT Analysis

13.6.7. Business Strategies

13.7. Pfizer Deutschland GmbH.

13.7.1. Company Details

13.7.2. Company Overview

13.7.3. Product Offerings

13.7.4. Key Developments

13.7.5. Financial Analysis

13.7.6. SWOT Analysis

13.7.7. Business Strategies

13.8. Pierrel S.p.A.

13.8.1. Company Details

13.8.2. Company Overview

13.8.3. Product Offerings

13.8.4. Key Developments

13.8.5. Financial Analysis

13.8.6. SWOT Analysis

13.8.7. Business Strategies

13.9. Primequal

13.9.1. Company Details

13.9.2. Company Overview

13.9.3. Product Offerings

13.9.4. Key Developments

13.9.5. Financial Analysis

13.9.6. SWOT Analysis

13.9.7. Business Strategies

13.10. SEPTODONT

13.10.1. Company Details

13.10.2. Company Overview

13.10.3. Product Offerings

13.10.4. Key Developments

13.10.5. Financial Analysis

13.10.6. SWOT Analysis

13.10.7. Business Strategies

13.11. Sunstar Suisse S.A.

13.11.1. Company Details

13.11.2. Company Overview

13.11.3. Product Offerings

13.11.4. Key Developments

13.11.5. Financial Analysis

13.11.6. SWOT Analysis

13.11.7. Business Strategies

13.12. Valeant

13.12.1. Company Details

13.12.2. Company Overview

13.12.3. Product Offerings

13.12.4. Key Developments

13.12.5. Financial Analysis

13.12.6. SWOT Analysis

13.12.7. Business Strategies

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com